Search

ImmVira announced that as a global first, its lead oncolytic virus therapy program MVR-T3011 IV (also known as T3011), obtained approval from National Medical Products Administration ('NMPA') for clinical trial [...]

Mika Medical, a Korean manufacturer specializing in syringe technology, namely the Comfort-in needleless syringe, has completed clinical trials with Yonsei University Severance Hospital and Catania University Medical School in Italy [...]

Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has received a clinical trial waiver from the National Medical Products Administration (NMPA) in China for Wakix (pitolisant), [...]

As the COVID-19 pandemic continues to alter ways of life across the globe, clinical trials must be adapted for participant safety while maintaining accuracy in the midst of the ongoing [...]